Ariel Dora Stern
机构: Alexander von Humboldt Professor, Hasso Plattner Institute, University of Potsdam
主页: hpi.de
每年引用次数
引用次数
引用: 2,859
H-指数: 26
I10-指数 : 46
出版物: 110
Recalls, innovation, and competitor response: Evidence from medical device firms
George P Ball , Jeffrey T Macher , Ariel D Stern
Harvard Business School
11
2019
DiGA VADEMECUM: How to Launch Digital Health Apps in the German Healthcare System
Jan B Brönneke , Jörg F Debatin , Julia Hagen , Philipp Kircher
MWV
5
2021
The central and unacknowledged role of the US Food and Drug Administration in the design and execution of medical device pivotal trials
Aaron V Kaplan , Ariel D Stern
JAMA cardiology 3 ( 1) 5 -6
5
2018
Product recalls and new product development: own firm distractions and competitor firm opportunities
George P Ball , Jeffrey T Macher , Ariel D Stern
Harvard Business School Working Paper 19 -028
3
2020
How Important is Editorial Gatekeeping? Evidence from Top Biomedical Journals
Joshua L Krieger , Kyle R Myers , Ariel D Stern
Review of Economics and Statistics 1 -33
1
2023
Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials. gov
Lars Masanneck , Ariel D Stern
Clinical Pharmacology & Therapeutics
2024
Differences in Care Team Response to Patient Portal Messages by Patient Race and Ethnicity
Mitchell Tang , Rebecca G Mishuris , Lily Payvandi , Ariel D Stern
JAMA Network Open 7 ( 3) e242618 -e242618
2024
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
Caroline Marra , Ariel D Stern
Clinical Pharmacology & Therapeutics
2024
Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510 (k) Clearance—Reply
Alexander O Everhart , Yi Zhu , Ariel D Stern ,
JAMA 329 ( 18) 1609 -1610
2023
Biosimilars And Follow-On Products/The Authors Reply
Bruce Feinberg , Ajeet Gajra , Sonia Oskouei , Ariel D Stern
Health Affairs 40 ( 9) 1515 -1516
2021
RECALLS, INNOVATION, AND COMPETITOR RESPONSE: EVIDENCE FROM MEDICAL DEVICE FIRMS JULY 2019
George P Ball , Jeffrey T Macher , Ariel D Stern
2019
FAILURES AND INNOVATION: EVIDENCE FROM MEDICAL DEVICE RECALLS
George P Ball , Jeffrey T Macher , Ariel D Stern
2018
Recalls and Innovation: Own and Competitor Firm Response
George P Ball , Jeffrey T Macher , Ariel D Stern
2018
Post-Market Surveillance of Software Medical Devices
Alexander O Everhart , Ariel D Stern
Ushering in safe, effective, secure, and ethical medicine in the digital era
Ariel D. Stern , William J. Gordon , Andrea R. Coravos
npj Digital Medicine 4 ( 1) 56 -56
2021
Artificial Intelligence and Clinical Decision Making: The New Nature of Medical Uncertainty.
Vinyas Harish , Felipe Morgado , Ariel D. Stern , Sunit Das
Academic Medicine 96 ( 1) 31 -36
1
2021
Innovation Incentives and Biomarkers.
Ariel D. Stern , Brian M. Alexander , Amitabh Chandra
Clinical Pharmacology & Therapeutics 103 ( 1) 34 -36
9
2018
The Impact Of Price Regulation On The Availability Of New Drugs In Germany
Ariel D. Stern , Felicitas Pietrulla , Annika Herr , Aaron S. Kesselheim
Health Affairs 38 ( 7) 1182 -1187
21
2019
Quantifying the use of connected digital products in clinical research.
Caroline Marra , Jacqueline L. Chen , Andrea Coravos , Ariel D. Stern
npj Digital Medicine 3 ( 1) 50
7
2020
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
Sara Gerke , Ariel D. Stern , Timo Minssen
npj Digital Medicine 3 ( 1) 1 -6
13
2020